BeergamaschiRMontomoliC. Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?Mult Scler2009; 15: 1532–1533.
2.
PolmanCHO’ConnorPWHavrdovaE. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med2006; 354: 899–910.
3.
MullenJTVartanianTKAtkinsMB. Melanoma complicating treatment with natalizumab for multiple sclerosis. N Engl J Med2008; 358: 647–648.
4.
PanzaraMABozicCSandrockAW. More on melanoma with transdifferentiation. N Engl J Med2008; 359: 99–99.
5.
CockburnMSwetterSMPengDKeeganTHDeapenDClarkeCA. Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it?J Am Acad Dermatol2008; 59: 1081–1085.
6.
TchilianEZOwenJJJenkinsonEJ. Anti-alpha 4 integrin antibody induces apoptosis in murine thymocytes and staphylococcal enterotoxin B-activated lymph node T cells. Immunology1997; 92: 321–327.
